Trifecta Capital Advisors, LLC

Position in ABBV — AbbVie Inc.

CIK 1962615 NORTHBROOK, IL

Position in ABBV

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$10,393,990

+$1,541,713 QoQ

Shares Held

41,305

+1.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

1.54%

of 13F equity value

Holder Rank

#903

of 4,153 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Trifecta Capital Advisors, LLC holds $49,578,365 across 11 Drug Manufacturers - General names. ABBV ranks #2 (21.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	25,670	$30,789,370
2	ABBV	AbbVie Inc. This page	41,305	$10,393,990
3	AMGN	Amgen Inc	16,502	$5,975,704
4	JNJ	Johnson & Johnson	3,836	$974,228
5	MRK	Merck & Co., Inc.	5,740	$737,590
6	GILD	Gilead Sciences, Inc.	3,202	$404,540
7	NVO	Novo Nordisk A S	4,016	$192,527
8	PFE	Pfizer Inc	4,277	$102,990

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$10,393,990	41,305	+1.5%	Shares	Sole	2026-08-03
2026-03-31	$8,852,277	40,702	+0.4%	Shares	Sole	2026-05-01
2025-12-31	$9,263,441	40,542	+1.5%	Shares	Sole	2026-01-30
2025-09-30	$9,244,929	39,928	+2.3%	Shares	Sole	2025-11-03
2025-06-30	$7,244,377	39,028	+4.5%	Shares	Sole	2025-07-23
2025-03-31	$7,828,505	37,364	+2.5%	Shares	Sole	2025-04-21
2024-12-31	$6,478,408	36,457	+21.6%	Shares	Sole	2025-02-04
2024-09-30	$5,921,042	29,983	+0.5%	Shares	Sole	2024-10-16
2024-06-30	$5,117,299	29,835	+3.7%	Shares	Sole	2024-08-07
2024-03-31	$5,238,106	28,765	+1158.9%	Shares	Sole	2024-04-16
2023-12-31	$354,106	2,285	-9.1%	Shares	Sole	2024-01-25
2023-09-30	$374,885	2,515	-1.1%	Shares	Sole	2023-11-01
2023-06-30	$342,753	2,544	0.0%	Shares	Sole	2023-08-14
2023-03-31	$405,437	2,544	+1.2%	Shares	Sole	2023-05-09
2022-12-31	$406,449	2,515	—	Shares	Sole	2023-01-18
No filing history on record for this holder in this stock.